Abstract
Of 311 colorectal cancers diagnosed in 1984-86 in the county of Ostergotland, Sweden, 179 were included in a case-control study, and, of these, 70 were investigated using immunohistochemical staining for p53 gene mutations. Alcohol use as well as medication with hydralazine-containing antihypertensive drugs, but not heredity were associated with p53 staining. The study is offered to illustrate the possible value of investigating molecularly defined tumour subtypes in relation to specific risk factors.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fredrikson, M., Axelson, O., Sun, XF. et al. A pilot study on risk factors and p53 gene expression in colorectal cancer. Br J Cancer 73, 1428–1430 (1996). https://doi.org/10.1038/bjc.1996.271
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.271
- Springer Nature Limited
This article is cited by
-
Lower Relative Contribution of Positive Family History to Colorectal Cancer Risk with Increasing Age: A Systematic Review and Meta-Analysis of 9.28 Million Individuals
American Journal of Gastroenterology (2018)
-
Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia
BMC Cancer (2003)